期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Portal vein thrombosis:Insight into physiopathology,diagnosis,and treatment 被引量:79
1
作者 Francesca R Ponziani Maria A Zocco +8 位作者 Chiara Campanale Emanuele Rinninella Annalisa Tortora Luca Di Maurizio Giuseppe Bombardieri raimondo de cristofaro Anna M de Gaetano Raffaele Landolfi Antonio Gasbarrini 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第2期143-155,共13页
Portal vein thrombosis (PVT) is a relatively common complication in patients with liver cirrhosis, but might also occur in absence of an overt liver disease. Several causes, either local or systemic, might play an imp... Portal vein thrombosis (PVT) is a relatively common complication in patients with liver cirrhosis, but might also occur in absence of an overt liver disease. Several causes, either local or systemic, might play an important role in PVT pathogenesis. Frequently, more than one risk factor could be identified; however, occasionally no single factor is discernable. Clinical examination, laboratory investigations, and imaging are helpful to provide a quick diagnosis, as prompt treatment might greatly affect a patient's outcome. In this review, we analyze the physiopathological mechanisms of PVT development, together with the hemodynamic and functional alterations related to this condition. Moreover, we describe the principal factors most frequently involved in PVT development and the recent knowledge concerning diagnostic and therapeutic procedures. Finally, we analyze the implications of PVT in the setting of liver transplantation and its possible influence on patients' future prognoses. 展开更多
关键词 Portal vein thrombosis Portal hypertension Thrombophilic factors Liver cirrhosis Liver transplantation ANTICOAGULANTS
下载PDF
Haemostatic system in inflammatory bowel diseases:New players in gut inflammation 被引量:18
2
作者 Franco Scaldaferri Stefano Lancellotti +1 位作者 Marco Pizzoferrato raimondo de cristofaro 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第5期594-608,共15页
Inflammation and coagulation constantly influence each other and are constantly in balance.Emerging evidence supports this statement in acute inflammatory diseases,such as sepsis,but it also seems to be very important... Inflammation and coagulation constantly influence each other and are constantly in balance.Emerging evidence supports this statement in acute inflammatory diseases,such as sepsis,but it also seems to be very important in chronic inflammatory settings,such as inflammatory bowel disease(IBD).Patients with Crohn's disease and ulcerative colitis have an increased risk of thromboembolic events,and several abnormalities concerning coagulation components occur in the endothelial cells of intestinal vessels,where most severe inflammatory abnormalities occur.The aims of this review are to update and classify the type of coagulation system abnormalities in IBD,and analyze the strict and delicate balance between coagulation and inflammation at the mucosal level.Recent studies on possible therapeutic applications arising from investigations on coagulation abnormalities associated with IBD pathogenesis will also be briefly presented and critically reviewed. 展开更多
关键词 Activated protein C COAGULATION Crohn'sdisease INFLAMMATION Inflammatory bowel disease PLATELETS Ulcerative colitis
下载PDF
Low ADAMTS-13/VWF ratio and altered gut–liver axis predict complications of advanced chronic liver disease:a pilot study
3
作者 Francesca Romana Ponziani Monica Sacco +7 位作者 Maira Tardugno Francesco Santopaolo Adriana Marsico Stefano Manna Stefano Lancellotti Antonio Gasbarrini raimondo de cristofaro Maurizio Pompili 《Gastroenterology Report》 SCIE EI 2022年第1期671-673,共3页
Introduction Liver cirrhosis is characterized by a delicate balance between thrombosis and bleeding.Parenchymal extinction due to microvascular thrombosis is involved in disease progression and anticoagulant therapy w... Introduction Liver cirrhosis is characterized by a delicate balance between thrombosis and bleeding.Parenchymal extinction due to microvascular thrombosis is involved in disease progression and anticoagulant therapy with low-molecular-weight heparin has been shown to reduce the frequency of hepatic decompensation[1].Dysbiosis and bacterial translocation,which are hallmarks of liver cirrhosis,can influence the coagulation system through inflammation or by the activation of Toll-like receptors on endothelial cells and platelets[2].However,little is known about the connections between the coagulation system,the occurrence of liver cirrhosis complications,and the gut microbiome. 展开更多
关键词 COMPLICATIONS inflammation BLEEDING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部